Vivanza Biosciences Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 11-07-2024
- Paid Up Capital ₹ 4.00 Cr
as on 11-07-2024
- Company Age 42 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.00 Cr
as on 11-07-2024
- Revenue 46.30%
(FY 2023)
- Profit 22.74%
(FY 2023)
- Ebitda 1370.69%
(FY 2023)
- Net Worth 14.86%
(FY 2023)
- Total Assets 78.16%
(FY 2023)
About Vivanza Biosciences
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 530057.
The Corporate was formerly known as Ivee Injectaa Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 4.00 Cr.
The company currently has active open charges totaling ₹3.00 Cr.
The Key Managerial Personnel (KMP) at Vivanza Biosciences Limited India are Jainil Bhatt as CFO and Avinash Bhojwani as Company Secretary. Hemant Parikh, Girish Bhatt, Jayendra Mehta, and Two other members serve as directors at the Company.
- CIN/LLPIN
L24110GJ1982PLC005057
- Company No.
005057
- Stock Symbol
BSE : 530057
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
06 Mar 1982
- Date of AGM
24 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Vivanza Biosciences Limited offer?
Vivanza Biosciences Limited offers a wide range of products and services, including Scalpels, Needles & Scissors, Surgical Needles, Surgical & Medical Consumables, Surgical Disposables, Orthopedic Equipment & Supplies, Plaster Room Equipment, Bandages & Dressing Disposables, Medical Gauze, Infusion Syringes & Supplies, Medical Tubes.
Who are the key members and board of directors at Vivanza Biosciences?
Executive Team (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Jainil Bhatt | CFO | 17-Jun-2016 | Current |
Jayendra Mehta | Managing Director | 25-Apr-2023 | Current |
Avinash Bhojwani | Company Secretary | 27-May-2022 | Current |
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Hemant Parikh | Director | 29-Mar-2019 | Current |
Girish Bhatt | Director | 28-Jun-2021 | Current |
Sunil Shah | Director | 06-Oct-2020 | Current |
Apeksha Vyas | Director | 25-Apr-2023 | Current |
Financial Performance and Corporate Structure Insights of Vivanza Biosciences.
Vivanza Biosciences Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 46.3% increase. The company also saw a substantial improvement in profitability, with a 22.74% increase in profit. The company's net worth Soared by an impressive increase of 14.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Vivanza Biosciences?
In 2023, Vivanza Biosciences had a promoter holding of 47.80% and a public holding of 52.21%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Vitaaglobal Bioscience Private LimitedActive 11 years 4 months
Hemant Parikh and Girish Bhatt are mutual person
- Vitale Beverages Private LimitedActive 16 years 7 months
Girish Bhatt and Jayendra Mehta are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
State Bank Of India Creation Date: 10 Jan 2017 | ₹3.00 Cr | Open |
How Many Employees Work at Vivanza Biosciences?
Unlock and access historical data on people associated with Vivanza Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vivanza Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vivanza Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.